Considering the importance of plasma membrane-localized GPR30 for breast cancer outcome [15,16], we have made considerable efforts to determine the mechanism by which the receptor anchors in the plasma membrane and how this mechanism relates to constitutive receptor activity. This evidence concerns the gene GPER1 and breast carcinoma.